ArticleJTO clinical and research reports2025

Combining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1-Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study.

Prashasti Agrawal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.